Published 1 day ago • loading... • Updated 1 day agoShow Less IconOn Wall Street, there's trouble stirring for biotech Summary by STATMany biotech investors are in a tough spot — losing money in what still seems like a positive year, if the XBI’s top-line performance is your barometer.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconSTATCenterFactualityOwnershipOn Wall Street, there's trouble stirring for biotechMany biotech investors are in a tough spot — losing money in what still seems like a positive year, if the XBI’s top-line performance is your barometer.1 day ago·Boston, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated1 day agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSTAT broke the news in Boston, United States 1 day ago on Thursday, October 15, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsWall Street Plus IconNew York City Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsWall Street Plus IconNew York City Plus IconShow All